Gastric Bypass

Optimal Timing of Gastric Bypass and Cholecystectomy When Both Procedures Clinically Indicated

Optimal Timing of Gastric Bypass and Cholecystectomy When Both Procedures Clinically Indicated

By

Roux-en-Y gastric bypass (RYGB) with simultaneous cholecystectomy had a significantly higher complication rate and took more than 1 hour longer than RYGB without cholecystectomy.

Nonvertebral Fracture Risk After Roux-en-Y Gastric Bypass

Nonvertebral Fracture Risk After Roux-en-Y Gastric Bypass

Researchers examined the nonvertebral fracture risk in adults with obesity who underwent Roux-en-Y gastric bypass vs adjustable gastric banding.

Gastric Bypass Outcomes in Severely Obese Teens

Gastric Bypass Outcomes in Severely Obese Teens

By

Severely obese adolescents who underwent gastric bypass surgery experienced significant weight loss that was maintained over long-term follow-up.

Gastric Bypass Tied to Decreased Psoriasis Risk

Gastric Bypass Tied to Decreased Psoriasis Risk

Gastric bypass, but not gastric banding, is associated with reduced risk of psoriasis, progression to severe psoriasis, and psoriatic arthritis.

Gastric Bypass May Significantly Reduce Long-Term Mortality Risk

Gastric Bypass May Significantly Reduce Long-Term Mortality Risk

By

Patients who undergo Roux-en-Y gastric bypass are less likely to die from obesity or other diseases than those who did not undergo the procedure 10 years later.

Diabetes Remission Rates After RYGB Vary With Study Duration

Diabetes Remission Rates After RYGB Vary With Study Duration

After Roux-en-Y gastric bypass surgery, variations in rates of diabetes remission are primarily related to differences in the definition of remission and study duration.

Episodes of Dizziness, Weakness After Bariatric Surgery

Episodes of Dizziness, Weakness After Bariatric Surgery

By

A patient came to the clinic to discuss her dizzy spells 4 years after her Roux-en-Y gastric bypass surgery.

Gastric Bypass Linked to Improved Achievement of Treatment Goals in Diabetes

Gastric Bypass Linked to Improved Achievement of Treatment Goals in Diabetes

The addition of Roux-en-Y gastric bypass to lifestyle-medical management is associated with improved achievement of treatment goals in type 2 diabetes.

Gastric Bypass Reduces Symptoms, Hormonal Responses to Hypoglycemia

Gastric Bypass Reduces Symptoms, Hormonal Responses to Hypoglycemia

Gastric bypass surgery is associated with reduced symptoms and neurohormonal responses to hypoglycemia, according to a study published in Diabetes.

Skeletal Muscle Proteome Affected by Obesity, Roux-en-Y Gastric Bypass

Skeletal Muscle Proteome Affected by Obesity, Roux-en-Y Gastric Bypass

An array of changes in protein abundance in skeletal muscle were observed before and after RYGB surgery.

DiaRem Score Identifies Which Type 2 Diabetes Patients Will Be Cured by Bariatric Surgery

DiaRem Score Identifies Which Type 2 Diabetes Patients Will Be Cured by Bariatric Surgery

As DiaRem score increases, the proportion of patients experiencing remission decreases.

Obese Patients With Diabetes Benefit From Combination Device-Drug Therapy

Obese Patients With Diabetes Benefit From Combination Device-Drug Therapy

By

The temporary 1-year intestinal bypass device with liraglutide boosts weight loss and improves diabetes control.

Type 2 Diabetes Remission Greater With Gastric Bypass vs Intensive Lifestyle Intervention

Type 2 Diabetes Remission Greater With Gastric Bypass vs Intensive Lifestyle Intervention

By

Compared with a rigorous lifestyle and medical intervention, gastric bypass surgery led to greater remission of type 2 diabetes.

Gastric Bypass Associated With Improved Long-Term Survival in Patients Older Than 35

Gastric Bypass Associated With Improved Long-Term Survival in Patients Older Than 35

Gastric bypass is linked to reduced mortality in patients aged older than 35.

High Prevalence of Symptoms, Hospitalizations Observed After Gastric Bypass Surgery

High Prevalence of Symptoms, Hospitalizations Observed After Gastric Bypass Surgery

By

Patients who underwent gastric bypass reported improved well-being, but symptoms and hospitalizations were high after the procedure.

Intra-Pancreatic Triacylglycerol Decreases With Weight Loss in Type 2 Diabetes

Intra-Pancreatic Triacylglycerol Decreases With Weight Loss in Type 2 Diabetes

A decrease was seen after gastric bypass for patients with type 2 diabetes, but not with normal glucose tolerance.

Bariatric Surgery Bested Drug Therapy in Type 2 Diabetes

Bariatric Surgery Bested Drug Therapy in Type 2 Diabetes

Surgery associated with significantly lower plasma lipids, CV risk, medication use vs. drug therapy.

Alcohol Tolerance Lower After Roux-en-Y Gastric Bypass

Alcohol Tolerance Lower After Roux-en-Y Gastric Bypass

Researchers found blood alcohol levels were doubled in women who had gastric bypass.

Roux-en-Y Gastric Bypass Improved Metabolic Profile

Roux-en-Y Gastric Bypass Improved Metabolic Profile

A 3.5-fold AMPK activity increase and 50% drop in oxidative stress 3 months after surgery.

Certain Drugs May Boost Weight Loss After RYGB

Certain Drugs May Boost Weight Loss After RYGB

Combining Roux-en-Y gastric bypass with a drug that targets the serotonin C receptor, like lorcaserin, may increase weight loss after the procedure.

Roux-en-Y Surgery Reduced Oxidative Stress Markers in Subcutaneous Fat

Roux-en-Y Surgery Reduced Oxidative Stress Markers in Subcutaneous Fat

Researchers saw a 50% decrease in oxidative stress.

Gastric Bypass vs. Duodenal Switch in Patients With Severe Obesity

Gastric Bypass vs. Duodenal Switch in Patients With Severe Obesity

By

Weight loss, improvements in metabolic parameters better with duodenal switch in patients with BMIs exceeding 50.

Roux-en-Y Surgery May Reverse Insulin Therapy in Type 2 Diabetes

Roux-en-Y Surgery May Reverse Insulin Therapy in Type 2 Diabetes

RYGB predicts insulin therapy cessation early after surgery, independent of weight.

Bariatric Surgery May Boost Survival

Bariatric Surgery May Boost Survival

By

Obese patients who underwent bariatric surgery had lower mortality rates compared with those who did not undergo the procedure.

Laparoscopic Gastric Bypass Surgery Safe in Type 2 Diabetes

Laparoscopic Gastric Bypass Surgery Safe in Type 2 Diabetes

By

Laparoscopic gastric bypass surgery has a complication and mortality rate comparable to some of the safest, most commonly performed procedures.

Weighing Benefits, Risks of Gastric Bypass vs. Gastric Banding

Weighing Benefits, Risks of Gastric Bypass vs. Gastric Banding

Gastric bypass helps patients lose more weight than gastric banding but also has a higher risk for complications and hospitalizations.

Gastric Bypass Bests Gastric Band in Obese Adults

Gastric Bypass Bests Gastric Band in Obese Adults

Obese adults may benefit more from gastric bypass than gastric band procedures in terms of weight loss and diabetes management.

Vagal Nerve Block Therapy for Morbid Obesity, Bariatric Surgery Trends Explored

Vagal Nerve Block Therapy for Morbid Obesity, Bariatric Surgery Trends Explored

Vagal nerve block therapy may be effective for weight loss in morbid obesity, and trends in bariatric surgery procedures have changed from 2006 to 2013.

Sign Up for Free e-Newsletters

CME Focus